Voltaren Topical Cream

Featured Article

Drugmaker Pharmos has announced that its new Voltaren cream to treat osteoarthritis (OA) is moving into Phase II clinical trials. This topical form of the non-steroidal anti-inflammatory drug (NSAID) is designed to deliver a high concentration of the med directly to the OA-affected joint. This could help patients who can't tolerate oral NSAIDs manage their OA pain.

Read more

More information on "Voltaren Topical Cream"

From Our Experts

See more SharePosts »

From Our Sources

More on Rheumatoid Arthritis »